Olink Holding

Olink Holding is a company listed under the stock ticker OLK (SE).

Acquisition, funding and merger involving Olink Holding.

• Thermo Fisher Scientific has announced the acquisition of Olink Holding  (posted on October 19 2023).

View the org chart displaying its 19 main executives

Most searched biographies at Olink Holding

• Jon Heimer, Chief Executive Officer and Director
• Johan Lund, Director
• Gregory Moore, Director

Popular executive movements at Olink Holding

• Maria Björk, who was Vice President, R&D, is promoted to Chief Research and Development Officer  (posted on January 19 2024).

Create your alert
to follow the executive moves at Olink Holding.

Olink Holding has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Olink Holding

• Press Release: Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease - Olink
• Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
• Olink Novel protein biomarkers associated with ischemic stroke outcomes
• Olink From biomarker discovery to a diagnostic protein panel for DLB
• Olink The proteogenomics of adiposity
• Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
• Olink Pharmacodynamic biomarkers for anti-IL6R therapy in COVID-19
• Olink
• Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
• Olink New diagnostic protein biomarkers for Kawasaki disease
• View more press releases Close

Social media about Olink Holding

• Olink Holding on Wikipedia, Google News & Yahoo Finance
• Olink Holding on LinkedIn, Twitter & YouTube

Contact by email its executives including Jon Heimer

Call Olink Holding at +46 18...

View the org chart

Register to receive your alert

Report an error